HHS: Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

Federal Register

Jan 29, 2026

Notice from the Office of Inspector General (OIG) in the Department of Health and Human Services (HHS) seeking comments on whether any additions or modifications are needed to the safe harbor regulations under the Federal anti-kickback statute or the exceptions to the civil monetary penalty provision prohibiting inducements to beneficiaries for emerging direct-to-consumer sales programs established by pharmaceutical manufacturers. Comments are due by March 30, 2026.

Healthcare business and finance · Legislation and regulations · Pharmacy and prescription drugs